In the case of Colombia, the management, the result of which exceeds the initial offer made by another proposer for the region of the Americasit included the participation of infectious disease doctor Carlos Álvarez, research professor at the National University of Colombia and WHO representative for Covid studies in the country.
Likewise, the accompaniment of a group of top-level experts composed by Dr. Hernando Gaitán, director of the Institute of Investigations National University Clinics.
The agreement is part of a research project carried out by several countries with the World Health Organization, including Colombia, which provides for the supply of 25,000 vaccines, which will be imported into the country under the management of INVIMA.
